Global Je Inactivated Vaccine Market Research Report 2025(Status and Outlook)
The JE inactivated vaccine is a biological preparation designed to induce immunity against Japanese encephalitis, a mosquito-borne viral infection prevalent in parts of Asia and the western Pacific. It is produced using inactivated (killed) JE virus strains, such as the SA14-14-2 or Beijing-1 strains, which are cultivated in Vero cells or primary hamster kidney cells. The inactivated virus cannot cause disease but stimulates the immune system to produce protective antibodies, providing a high level of safety, especially for vulnerable populations like children, immunocompromised individuals, and travelers. This vaccine is typically administered in a multi-dose schedule, often with a booster dose to ensure long-term protection, and is a critical tool in public health strategies for regions where Japanese encephalitis is endemic or epidemic.
The global Je Inactivated Vaccine market size was estimated at USD 1150.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Je Inactivated Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Je Inactivated Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Je Inactivated Vaccine market.
Global Je Inactivated Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bharat Biotech
Biological E. Limited
Biken
Seqirus
Liaoning Chengda
Valneva Austria GmbH
Market Segmentation (by Type)
Hamster Kidney Cells
Vero Cells
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Je Inactivated Vaccine Market
Overview of the regional outlook of the Je Inactivated Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Je Inactivated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Je Inactivated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Je Inactivated Vaccine market size was estimated at USD 1150.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Je Inactivated Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Je Inactivated Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Je Inactivated Vaccine market.
Global Je Inactivated Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bharat Biotech
Biological E. Limited
Biken
Seqirus
Liaoning Chengda
Valneva Austria GmbH
Market Segmentation (by Type)
Hamster Kidney Cells
Vero Cells
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Je Inactivated Vaccine Market
Overview of the regional outlook of the Je Inactivated Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Je Inactivated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Je Inactivated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Je Inactivated Vaccine
1.2 Key Market Segments
1.2.1 Je Inactivated Vaccine Segment by Type
1.2.2 Je Inactivated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 JE INACTIVATED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Je Inactivated Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Je Inactivated Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 JE INACTIVATED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Je Inactivated Vaccine Product Life Cycle
3.3 Global Je Inactivated Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Je Inactivated Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Je Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Je Inactivated Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Je Inactivated Vaccine Market Competitive Situation and Trends
3.8.1 Je Inactivated Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Je Inactivated Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 JE INACTIVATED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Je Inactivated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF JE INACTIVATED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Je Inactivated Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Je Inactivated Vaccine Market
5.7 ESG Ratings of Leading Companies
6 JE INACTIVATED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Je Inactivated Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Je Inactivated Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Je Inactivated Vaccine Price by Type (2020-2025)
7 JE INACTIVATED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Je Inactivated Vaccine Market Sales by Application (2020-2025)
7.3 Global Je Inactivated Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Je Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
8 JE INACTIVATED VACCINE MARKET SALES BY REGION
8.1 Global Je Inactivated Vaccine Sales by Region
8.1.1 Global Je Inactivated Vaccine Sales by Region
8.1.2 Global Je Inactivated Vaccine Sales Market Share by Region
8.2 Global Je Inactivated Vaccine Market Size by Region
8.2.1 Global Je Inactivated Vaccine Market Size by Region
8.2.2 Global Je Inactivated Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Je Inactivated Vaccine Sales by Country
8.3.2 North America Je Inactivated Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Je Inactivated Vaccine Sales by Country
8.4.2 Europe Je Inactivated Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Je Inactivated Vaccine Sales by Region
8.5.2 Asia Pacific Je Inactivated Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Je Inactivated Vaccine Sales by Country
8.6.2 South America Je Inactivated Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Je Inactivated Vaccine Sales by Region
8.7.2 Middle East and Africa Je Inactivated Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 JE INACTIVATED VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Je Inactivated Vaccine by Region(2020-2025)
9.2 Global Je Inactivated Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Je Inactivated Vaccine Production
9.4.1 North America Je Inactivated Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Je Inactivated Vaccine Production
9.5.1 Europe Je Inactivated Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Je Inactivated Vaccine Production (2020-2025)
9.6.1 Japan Je Inactivated Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Je Inactivated Vaccine Production (2020-2025)
9.7.1 China Je Inactivated Vaccine Production Growth Rate (2020-2025)
9.7.2 China Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bharat Biotech
10.1.1 Bharat Biotech Basic Information
10.1.2 Bharat Biotech Je Inactivated Vaccine Product Overview
10.1.3 Bharat Biotech Je Inactivated Vaccine Product Market Performance
10.1.4 Bharat Biotech Business Overview
10.1.5 Bharat Biotech SWOT Analysis
10.1.6 Bharat Biotech Recent Developments
10.2 Biological E. Limited
10.2.1 Biological E. Limited Basic Information
10.2.2 Biological E. Limited Je Inactivated Vaccine Product Overview
10.2.3 Biological E. Limited Je Inactivated Vaccine Product Market Performance
10.2.4 Biological E. Limited Business Overview
10.2.5 Biological E. Limited SWOT Analysis
10.2.6 Biological E. Limited Recent Developments
10.3 Biken
10.3.1 Biken Basic Information
10.3.2 Biken Je Inactivated Vaccine Product Overview
10.3.3 Biken Je Inactivated Vaccine Product Market Performance
10.3.4 Biken Business Overview
10.3.5 Biken SWOT Analysis
10.3.6 Biken Recent Developments
10.4 Seqirus
10.4.1 Seqirus Basic Information
10.4.2 Seqirus Je Inactivated Vaccine Product Overview
10.4.3 Seqirus Je Inactivated Vaccine Product Market Performance
10.4.4 Seqirus Business Overview
10.4.5 Seqirus Recent Developments
10.5 Liaoning Chengda
10.5.1 Liaoning Chengda Basic Information
10.5.2 Liaoning Chengda Je Inactivated Vaccine Product Overview
10.5.3 Liaoning Chengda Je Inactivated Vaccine Product Market Performance
10.5.4 Liaoning Chengda Business Overview
10.5.5 Liaoning Chengda Recent Developments
10.6 Valneva Austria GmbH
10.6.1 Valneva Austria GmbH Basic Information
10.6.2 Valneva Austria GmbH Je Inactivated Vaccine Product Overview
10.6.3 Valneva Austria GmbH Je Inactivated Vaccine Product Market Performance
10.6.4 Valneva Austria GmbH Business Overview
10.6.5 Valneva Austria GmbH Recent Developments
11 JE INACTIVATED VACCINE MARKET FORECAST BY REGION
11.1 Global Je Inactivated Vaccine Market Size Forecast
11.2 Global Je Inactivated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Je Inactivated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Je Inactivated Vaccine Market Size Forecast by Region
11.2.4 South America Je Inactivated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Je Inactivated Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Je Inactivated Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Je Inactivated Vaccine by Type (2026-2033)
12.1.2 Global Je Inactivated Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Je Inactivated Vaccine by Type (2026-2033)
12.2 Global Je Inactivated Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Je Inactivated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Je Inactivated Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Je Inactivated Vaccine
1.2 Key Market Segments
1.2.1 Je Inactivated Vaccine Segment by Type
1.2.2 Je Inactivated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 JE INACTIVATED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Je Inactivated Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Je Inactivated Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 JE INACTIVATED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Je Inactivated Vaccine Product Life Cycle
3.3 Global Je Inactivated Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Je Inactivated Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Je Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Je Inactivated Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Je Inactivated Vaccine Market Competitive Situation and Trends
3.8.1 Je Inactivated Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Je Inactivated Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 JE INACTIVATED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Je Inactivated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF JE INACTIVATED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Je Inactivated Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Je Inactivated Vaccine Market
5.7 ESG Ratings of Leading Companies
6 JE INACTIVATED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Je Inactivated Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Je Inactivated Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Je Inactivated Vaccine Price by Type (2020-2025)
7 JE INACTIVATED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Je Inactivated Vaccine Market Sales by Application (2020-2025)
7.3 Global Je Inactivated Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Je Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
8 JE INACTIVATED VACCINE MARKET SALES BY REGION
8.1 Global Je Inactivated Vaccine Sales by Region
8.1.1 Global Je Inactivated Vaccine Sales by Region
8.1.2 Global Je Inactivated Vaccine Sales Market Share by Region
8.2 Global Je Inactivated Vaccine Market Size by Region
8.2.1 Global Je Inactivated Vaccine Market Size by Region
8.2.2 Global Je Inactivated Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Je Inactivated Vaccine Sales by Country
8.3.2 North America Je Inactivated Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Je Inactivated Vaccine Sales by Country
8.4.2 Europe Je Inactivated Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Je Inactivated Vaccine Sales by Region
8.5.2 Asia Pacific Je Inactivated Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Je Inactivated Vaccine Sales by Country
8.6.2 South America Je Inactivated Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Je Inactivated Vaccine Sales by Region
8.7.2 Middle East and Africa Je Inactivated Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 JE INACTIVATED VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Je Inactivated Vaccine by Region(2020-2025)
9.2 Global Je Inactivated Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Je Inactivated Vaccine Production
9.4.1 North America Je Inactivated Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Je Inactivated Vaccine Production
9.5.1 Europe Je Inactivated Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Je Inactivated Vaccine Production (2020-2025)
9.6.1 Japan Je Inactivated Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Je Inactivated Vaccine Production (2020-2025)
9.7.1 China Je Inactivated Vaccine Production Growth Rate (2020-2025)
9.7.2 China Je Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bharat Biotech
10.1.1 Bharat Biotech Basic Information
10.1.2 Bharat Biotech Je Inactivated Vaccine Product Overview
10.1.3 Bharat Biotech Je Inactivated Vaccine Product Market Performance
10.1.4 Bharat Biotech Business Overview
10.1.5 Bharat Biotech SWOT Analysis
10.1.6 Bharat Biotech Recent Developments
10.2 Biological E. Limited
10.2.1 Biological E. Limited Basic Information
10.2.2 Biological E. Limited Je Inactivated Vaccine Product Overview
10.2.3 Biological E. Limited Je Inactivated Vaccine Product Market Performance
10.2.4 Biological E. Limited Business Overview
10.2.5 Biological E. Limited SWOT Analysis
10.2.6 Biological E. Limited Recent Developments
10.3 Biken
10.3.1 Biken Basic Information
10.3.2 Biken Je Inactivated Vaccine Product Overview
10.3.3 Biken Je Inactivated Vaccine Product Market Performance
10.3.4 Biken Business Overview
10.3.5 Biken SWOT Analysis
10.3.6 Biken Recent Developments
10.4 Seqirus
10.4.1 Seqirus Basic Information
10.4.2 Seqirus Je Inactivated Vaccine Product Overview
10.4.3 Seqirus Je Inactivated Vaccine Product Market Performance
10.4.4 Seqirus Business Overview
10.4.5 Seqirus Recent Developments
10.5 Liaoning Chengda
10.5.1 Liaoning Chengda Basic Information
10.5.2 Liaoning Chengda Je Inactivated Vaccine Product Overview
10.5.3 Liaoning Chengda Je Inactivated Vaccine Product Market Performance
10.5.4 Liaoning Chengda Business Overview
10.5.5 Liaoning Chengda Recent Developments
10.6 Valneva Austria GmbH
10.6.1 Valneva Austria GmbH Basic Information
10.6.2 Valneva Austria GmbH Je Inactivated Vaccine Product Overview
10.6.3 Valneva Austria GmbH Je Inactivated Vaccine Product Market Performance
10.6.4 Valneva Austria GmbH Business Overview
10.6.5 Valneva Austria GmbH Recent Developments
11 JE INACTIVATED VACCINE MARKET FORECAST BY REGION
11.1 Global Je Inactivated Vaccine Market Size Forecast
11.2 Global Je Inactivated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Je Inactivated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Je Inactivated Vaccine Market Size Forecast by Region
11.2.4 South America Je Inactivated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Je Inactivated Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Je Inactivated Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Je Inactivated Vaccine by Type (2026-2033)
12.1.2 Global Je Inactivated Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Je Inactivated Vaccine by Type (2026-2033)
12.2 Global Je Inactivated Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Je Inactivated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Je Inactivated Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Je Inactivated Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Je Inactivated Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Je Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Je Inactivated Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Je Inactivated Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Je Inactivated Vaccine as of 2024)
Table 10. Global Market Je Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Je Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Je Inactivated Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Je Inactivated Vaccine Sales by Type (K MT)
Table 26. Global Je Inactivated Vaccine Market Size by Type (M USD)
Table 27. Global Je Inactivated Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Je Inactivated Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Je Inactivated Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Je Inactivated Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Je Inactivated Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Je Inactivated Vaccine Sales (K MT) by Application
Table 33. Global Je Inactivated Vaccine Market Size by Application
Table 34. Global Je Inactivated Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Je Inactivated Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Je Inactivated Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Je Inactivated Vaccine Market Share by Application (2020-2025)
Table 38. Global Je Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Je Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Je Inactivated Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Je Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Je Inactivated Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Je Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Je Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Je Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Je Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Je Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Je Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Je Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Je Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Je Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Je Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Je Inactivated Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Je Inactivated Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Je Inactivated Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Bharat Biotech Basic Information
Table 62. Bharat Biotech Je Inactivated Vaccine Product Overview
Table 63. Bharat Biotech Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Bharat Biotech Business Overview
Table 65. Bharat Biotech SWOT Analysis
Table 66. Bharat Biotech Recent Developments
Table 67. Biological E. Limited Basic Information
Table 68. Biological E. Limited Je Inactivated Vaccine Product Overview
Table 69. Biological E. Limited Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Biological E. Limited Business Overview
Table 71. Biological E. Limited SWOT Analysis
Table 72. Biological E. Limited Recent Developments
Table 73. Biken Basic Information
Table 74. Biken Je Inactivated Vaccine Product Overview
Table 75. Biken Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Biken Business Overview
Table 77. Biken SWOT Analysis
Table 78. Biken Recent Developments
Table 79. Seqirus Basic Information
Table 80. Seqirus Je Inactivated Vaccine Product Overview
Table 81. Seqirus Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Seqirus Business Overview
Table 83. Seqirus Recent Developments
Table 84. Liaoning Chengda Basic Information
Table 85. Liaoning Chengda Je Inactivated Vaccine Product Overview
Table 86. Liaoning Chengda Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Liaoning Chengda Business Overview
Table 88. Liaoning Chengda Recent Developments
Table 89. Valneva Austria GmbH Basic Information
Table 90. Valneva Austria GmbH Je Inactivated Vaccine Product Overview
Table 91. Valneva Austria GmbH Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Valneva Austria GmbH Business Overview
Table 93. Valneva Austria GmbH Recent Developments
Table 94. Global Je Inactivated Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 95. Global Je Inactivated Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Je Inactivated Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 97. North America Je Inactivated Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Je Inactivated Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 99. Europe Je Inactivated Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Je Inactivated Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 101. Asia Pacific Je Inactivated Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Je Inactivated Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 103. South America Je Inactivated Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Je Inactivated Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Je Inactivated Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Je Inactivated Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 107. Global Je Inactivated Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Je Inactivated Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 109. Global Je Inactivated Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 110. Global Je Inactivated Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Je Inactivated Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Je Inactivated Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Je Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Je Inactivated Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Je Inactivated Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Je Inactivated Vaccine as of 2024)
Table 10. Global Market Je Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Je Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Je Inactivated Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Je Inactivated Vaccine Sales by Type (K MT)
Table 26. Global Je Inactivated Vaccine Market Size by Type (M USD)
Table 27. Global Je Inactivated Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Je Inactivated Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Je Inactivated Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Je Inactivated Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Je Inactivated Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Je Inactivated Vaccine Sales (K MT) by Application
Table 33. Global Je Inactivated Vaccine Market Size by Application
Table 34. Global Je Inactivated Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Je Inactivated Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Je Inactivated Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Je Inactivated Vaccine Market Share by Application (2020-2025)
Table 38. Global Je Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Je Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Je Inactivated Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Je Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Je Inactivated Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Je Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Je Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Je Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Je Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Je Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Je Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Je Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Je Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Je Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Je Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Je Inactivated Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Je Inactivated Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Je Inactivated Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Je Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Bharat Biotech Basic Information
Table 62. Bharat Biotech Je Inactivated Vaccine Product Overview
Table 63. Bharat Biotech Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Bharat Biotech Business Overview
Table 65. Bharat Biotech SWOT Analysis
Table 66. Bharat Biotech Recent Developments
Table 67. Biological E. Limited Basic Information
Table 68. Biological E. Limited Je Inactivated Vaccine Product Overview
Table 69. Biological E. Limited Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Biological E. Limited Business Overview
Table 71. Biological E. Limited SWOT Analysis
Table 72. Biological E. Limited Recent Developments
Table 73. Biken Basic Information
Table 74. Biken Je Inactivated Vaccine Product Overview
Table 75. Biken Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Biken Business Overview
Table 77. Biken SWOT Analysis
Table 78. Biken Recent Developments
Table 79. Seqirus Basic Information
Table 80. Seqirus Je Inactivated Vaccine Product Overview
Table 81. Seqirus Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Seqirus Business Overview
Table 83. Seqirus Recent Developments
Table 84. Liaoning Chengda Basic Information
Table 85. Liaoning Chengda Je Inactivated Vaccine Product Overview
Table 86. Liaoning Chengda Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Liaoning Chengda Business Overview
Table 88. Liaoning Chengda Recent Developments
Table 89. Valneva Austria GmbH Basic Information
Table 90. Valneva Austria GmbH Je Inactivated Vaccine Product Overview
Table 91. Valneva Austria GmbH Je Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Valneva Austria GmbH Business Overview
Table 93. Valneva Austria GmbH Recent Developments
Table 94. Global Je Inactivated Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 95. Global Je Inactivated Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Je Inactivated Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 97. North America Je Inactivated Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Je Inactivated Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 99. Europe Je Inactivated Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Je Inactivated Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 101. Asia Pacific Je Inactivated Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Je Inactivated Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 103. South America Je Inactivated Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Je Inactivated Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Je Inactivated Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Je Inactivated Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 107. Global Je Inactivated Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Je Inactivated Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 109. Global Je Inactivated Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 110. Global Je Inactivated Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Je Inactivated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Je Inactivated Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Je Inactivated Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Je Inactivated Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Je Inactivated Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Je Inactivated Vaccine Product Life Cycle
Figure 13. Je Inactivated Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Je Inactivated Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Je Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Je Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Je Inactivated Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Je Inactivated Vaccine
Figure 19. Global Je Inactivated Vaccine Market PEST Analysis
Figure 20. Global Je Inactivated Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Je Inactivated Vaccine Market Share by Type
Figure 27. Sales Market Share of Je Inactivated Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Je Inactivated Vaccine by Type in 2024
Figure 29. Market Size Share of Je Inactivated Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Je Inactivated Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Je Inactivated Vaccine Market Share by Application
Figure 33. Global Je Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Je Inactivated Vaccine Sales Market Share by Application in 2024
Figure 35. Global Je Inactivated Vaccine Market Share by Application (2020-2025)
Figure 36. Global Je Inactivated Vaccine Market Share by Application in 2024
Figure 37. Global Je Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Je Inactivated Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Je Inactivated Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Je Inactivated Vaccine Sales Market Share by Country in 2024
Figure 43. North America Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Je Inactivated Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Je Inactivated Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Je Inactivated Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Je Inactivated Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Je Inactivated Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Je Inactivated Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Je Inactivated Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Je Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Je Inactivated Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Je Inactivated Vaccine Market Size Market Share by Region in 2024
Figure 68. China Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Je Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Je Inactivated Vaccine Sales Market Share by Country in 2024
Figure 80. South America Je Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Je Inactivated Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Je Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Je Inactivated Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Je Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Je Inactivated Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Je Inactivated Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Je Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Je Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Je Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Je Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Je Inactivated Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Je Inactivated Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Je Inactivated Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Je Inactivated Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Je Inactivated Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Je Inactivated Vaccine Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Je Inactivated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Je Inactivated Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Je Inactivated Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Je Inactivated Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Je Inactivated Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Je Inactivated Vaccine Product Life Cycle
Figure 13. Je Inactivated Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Je Inactivated Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Je Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Je Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Je Inactivated Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Je Inactivated Vaccine
Figure 19. Global Je Inactivated Vaccine Market PEST Analysis
Figure 20. Global Je Inactivated Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Je Inactivated Vaccine Market Share by Type
Figure 27. Sales Market Share of Je Inactivated Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Je Inactivated Vaccine by Type in 2024
Figure 29. Market Size Share of Je Inactivated Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Je Inactivated Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Je Inactivated Vaccine Market Share by Application
Figure 33. Global Je Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Je Inactivated Vaccine Sales Market Share by Application in 2024
Figure 35. Global Je Inactivated Vaccine Market Share by Application (2020-2025)
Figure 36. Global Je Inactivated Vaccine Market Share by Application in 2024
Figure 37. Global Je Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Je Inactivated Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Je Inactivated Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Je Inactivated Vaccine Sales Market Share by Country in 2024
Figure 43. North America Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Je Inactivated Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Je Inactivated Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Je Inactivated Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Je Inactivated Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Je Inactivated Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Je Inactivated Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Je Inactivated Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Je Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Je Inactivated Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Je Inactivated Vaccine Market Size Market Share by Region in 2024
Figure 68. China Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Je Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Je Inactivated Vaccine Sales Market Share by Country in 2024
Figure 80. South America Je Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Je Inactivated Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Je Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Je Inactivated Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Je Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Je Inactivated Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Je Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Je Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Je Inactivated Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Je Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Je Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Je Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Je Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Je Inactivated Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Je Inactivated Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Je Inactivated Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Je Inactivated Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Je Inactivated Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Je Inactivated Vaccine Market Share Forecast by Application (2026-2033)
